🤔 This week: TSLA Q3 earnings report - is now the right time to buy the EV giant?Explore TSLA Data

Biden administration proposes free over-the-counter birth control

Published 10/21/2024, 05:02 AM
Updated 10/21/2024, 05:46 AM
© Reuters. FILE PHOTO: Jennifer Klein, Director of the White House Gender Policy Council, answers questions during the daily press briefing at the White House in Washington, U.S., January 22, 2024. REUTERS/Evelyn Hockstein/File Photo
PRGO
-

By Ahmed Aboulenein

WASHINGTON (Reuters) - The Biden administration is proposing a rule that would provide women with private insurance access to over-the-counter birth control pills and other contraceptives at no cost, the White House said on Monday.

The rule, which expands a federal mandate requiring health insurers to cover preventative care services at no cost to patients under the Affordable Care Act, is being proposed by the Departments of Health and Human Services, Labor, and the Treasury and would come into effect in 2025 if finalized.

"This rule, once finalized, will expand contraception coverage for 52 million women of reproductive age with private health insurance," White House Gender Policy Council Director Jennifer Klein said during a briefing.

"For the first time ever, women would be able to obtain over-the-counter contraception without a prescription at no additional cost, and health plans would have to cover even more prescribed contraceptives without cost sharing," she said.

Perrigo Co (NYSE:PRGO)'s Opill is currently the only daily birth control pill approved for sale without a prescription by the U.S. Food and Drug Administration, but the proposed rule covers other forms of over-the-counter contraceptives, including emergency contraception such as morning after pill Plan B, spermicides, birth control sponges, and condoms.

The rule will also require that health plans cover all FDA-approved contraceptive drugs and some devices, including IUDs, without cost sharing in many cases.

The rule will also require health plans to cover every FDA-approved contraceptive drug or drug-led combination product, such as IUDs, without cost sharing unless the plan also covers a therapeutic equivalent without cost sharing, and would require plans to disclose that OTC contraceptives are covered with cost sharing or a prescription.

© Reuters. A pack of birth control pills is displayed in this illustration picture taken in Philadelphia, Pennsylvania, U.S., July 11, 2022. REUTERS/Hannah Beier/Illustration/File Photo

The proposal comes just two weeks before the 2024 presidential election, in which abortion rights has been a key issue following the Supreme Court's decision to overturn Roe v Wade in 2022. Vice President Kamala Harris, the Democratic nominee, has made access to abortion central to her campaign. 

Republican rival former President Donald Trump has bragged about appointing three of the conservative justices who made the ruling but has since said abortion laws should be determined by U.S. states, stopping short of proposing a national ban that could imperil his chances with swing voters in the November election.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.